293 related articles for article (PubMed ID: 30475788)
1. THE OCCURRENCE, CHARACTERISTICS, MANAGEMENT, AND PROGNOSIS OF RETINAL PIGMENT EPITHELIUM TEARS IN PATIENTS WITH POLYPOIDAL CHOROIDAL VASCULOPATHY: A Retrospective Study of 397 Patients.
Zhao XY; Xia S; Luo MY; Wang EQ; Chen YX
Retina; 2020 Mar; 40(3):477-489. PubMed ID: 30475788
[TBL] [Abstract][Full Text] [Related]
2. Pigment epithelial tears after ranibizumab injection in polypoidal choroidal vasculopathy and typical age-related macular degeneration.
Shin JY; Choi M; Chung B; Byeon SH
Graefes Arch Clin Exp Ophthalmol; 2015 Dec; 253(12):2151-60. PubMed ID: 25744335
[TBL] [Abstract][Full Text] [Related]
3. RETINAL PIGMENT EPITHELIAL TEAR AFTER INTRAVITREAL RANIBIZUMAB TREATMENT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
Cho HJ; Kim HS; Yoo SG; Han JI; Lew YJ; Cho SW; Lee TG; Kim JW
Retina; 2016 Oct; 36(10):1851-9. PubMed ID: 27074658
[TBL] [Abstract][Full Text] [Related]
4. CHOROIDAL THICKNESS AS A PROGNOSTIC FACTOR OF PHOTODYNAMIC THERAPY WITH AFLIBERCEPT OR RANIBIZUMAB FOR POLYPOIDAL CHOROIDAL VASCULOPATHY.
Sakurada Y; Sugiyama A; Tanabe N; Kikushima W; Kume A; Iijima H
Retina; 2017 Oct; 37(10):1866-1872. PubMed ID: 28002268
[TBL] [Abstract][Full Text] [Related]
5. Response of vascular pigment epithelium detachment due to age-related macular degeneration to monthly treatment with ranibizumab: the prospective, multicentre RECOVER study.
Clemens CR; Wolf A; Alten F; Milojcic C; Heiduschka P; Eter N
Acta Ophthalmol; 2017 Nov; 95(7):683-689. PubMed ID: 28084038
[TBL] [Abstract][Full Text] [Related]
6. Retinal Pigment Epithelial Tear After Intravitreal Ranibizumab Treatment for Retinal Angiomatous Proliferation.
Cho HJ; Kim HS; Yoo SG; Han JI; Lew YJ; Cho SW; Lee TG; Kim JW
Am J Ophthalmol; 2015 Nov; 160(5):1000-1005.e2. PubMed ID: 26210865
[TBL] [Abstract][Full Text] [Related]
7. SPATIAL PATTERN OF RETINAL PIGMENT EPITHELIUM TEAR DEVELOPMENT AND PROGRESSION AFTER ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION.
Fukui T; Ishikawa K; Shiose S; Kano K; Mori K; Notomi S; Sonoda KH
Retin Cases Brief Rep; 2024 May; 18(3):371-377. PubMed ID: 36730109
[TBL] [Abstract][Full Text] [Related]
8. Quantitative Changes in Pigment Epithelial Detachment Area and Volume Predict Retreatment in Polypoidal Choroidal Vasculopathy.
Chan EW; Eldeeb M; Lingam G; Thomas D; Bhargava M; Chee CK
Am J Ophthalmol; 2017 May; 177():195-205. PubMed ID: 28007451
[TBL] [Abstract][Full Text] [Related]
9. POSTTREATMENT POLYP REGRESSION AND RISK OF MASSIVE SUBMACULAR HEMORRHAGE IN EYES WITH POLYPOIDAL CHOROIDAL VASCULOPATHY.
Cho JH; Park YJ; Cho SC; Ryoo NK; Cho KH; Park SJ; Park KH; Woo SJ
Retina; 2020 Mar; 40(3):468-476. PubMed ID: 30422938
[TBL] [Abstract][Full Text] [Related]
10. Visual Outcome and Fluid Changes Between Eyes With Polypoidal Choroidal Vasculopathy Receiving Biosimilar CKD-701 or Reference Ranibizumab Therapy: A Post Hoc Analysis of a Phase 3 Randomized Clinical Trial.
Nam KT; Yun C; Lee YJ; Choi M; Kang D; Oh J
Curr Eye Res; 2024 Jun; 49(6):663-670. PubMed ID: 38450631
[TBL] [Abstract][Full Text] [Related]
11. Subfoveal choroidal thickness as a predictor of treatment response to anti-vascular endothelial growth factor therapy for polypoidal choroidal vasculopathy.
Kim H; Lee SC; Kwon KY; Lee JH; Koh HJ; Byeon SH; Kim SS; Kim M; Lee CS
Graefes Arch Clin Exp Ophthalmol; 2016 Aug; 254(8):1497-1503. PubMed ID: 26626772
[TBL] [Abstract][Full Text] [Related]
12. RETINAL PIGMENT EPITHELIAL TEAR AND ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION: Clinical Course and Long-Term Prognosis.
Heimes B; Farecki ML; Bartels S; Barrelmann A; Gutfleisch M; Spital G; Lommatzsch A; Pauleikhoff D
Retina; 2016 May; 36(5):868-74. PubMed ID: 26655607
[TBL] [Abstract][Full Text] [Related]
13. Retinal pigment epithelial tear in polypoidal choroidal vasculopathy.
Tsujikawa A; Hirami Y; Nakanishi H; Ojima Y; Aikawa H; Tamura H; Otani A; Yoshimura N
Retina; 2007 Sep; 27(7):832-8. PubMed ID: 17891005
[TBL] [Abstract][Full Text] [Related]
14. DIFFERENCE BETWEEN PACHYCHOROID AND NONPACHYCHOROID POLYPOIDAL CHOROIDAL VASCULOPATHY AND THEIR RESPONSE TO ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY.
Chang YC; Cheng CK
Retina; 2020 Jul; 40(7):1403-1411. PubMed ID: 31181038
[TBL] [Abstract][Full Text] [Related]
15. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY FINDINGS OF CLASSIC CHOROIDAL NEOVASCULARIZATION IN POLYPOIDAL CHOROIDAL VASCULOPATHY.
Izumi T; Koizumi H; Maruko I; Hasegawa T; Iida T
Retina; 2022 Jan; 42(1):123-128. PubMed ID: 34292224
[TBL] [Abstract][Full Text] [Related]
16. Anatomical and visual outcomes of ranibizumab injections in retinal pigment epithelium tears.
Erol MK; Ozdemir O; Coban DT; Ceran BB; Sari ES
Arq Bras Oftalmol; 2015; 78(3):168-72. PubMed ID: 26222106
[TBL] [Abstract][Full Text] [Related]
17. Effects of photodynamic therapy plus intravitreal aflibercept with subtenon triamcinolone injections for aflibercept-resistant polypoidal choroidal vasculopathy.
Sakai T; Kato N; Kubota M; Tsuneoka H
Graefes Arch Clin Exp Ophthalmol; 2017 Aug; 255(8):1565-1571. PubMed ID: 28601912
[TBL] [Abstract][Full Text] [Related]
18. COMPARISON OF OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHIC CHANGES AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY ALONE OR IN COMBINATION WITH PHOTODYNAMIC THERAPY IN POLYPOIDAL CHOROIDAL VASCULOPATHY.
Teo KYC; Yanagi Y; Lee SY; Yeo IYS; Tan GSW; Mathur R; Chan CM; Wong TY; Cheung CMG
Retina; 2018 Sep; 38(9):1675-1687. PubMed ID: 28767554
[TBL] [Abstract][Full Text] [Related]
19. Factors predicting 2-year treatment results of ranibizumab therapy for polypoidal choroidal vasculopathy in eyes with good baseline visual acuity.
Mori R; Tanaka K; Yuzawa M
Medicine (Baltimore); 2018 Jun; 97(25):e11188. PubMed ID: 29924037
[TBL] [Abstract][Full Text] [Related]
20. Retinal pigment epithelial tears after intravitreal bevacizumab injection for neovascular age-related macular degeneration.
Chan CK; Meyer CH; Gross JG; Abraham P; Nuthi AS; Kokame GT; Lin SG; Rauser ME; Kaiser PK
Retina; 2007 Jun; 27(5):541-51. PubMed ID: 17558314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
